Bioinformatics in Precision Medicine: Recent Advances in Biomarker Discovery, Multi-Omics Integration, and Personalized Therapeutics
Biotechnology Frontiers · 26.03.2026 · 6 (1) · 68-71
DOI: 10.51470/bf.2026.6.1.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Frontiers, online erschienen am 22.04.2026. Verfasst von Vaishnavi Sharma.
Abstract (Originalsprache)
Precision medicine has transformed modern healthcare by enabling individualized disease prevention, diagnosis, and treatment based on a patient’s unique genetic, molecular, environmental, and lifestyle characteristics. The rapid expansion of next-generation sequencing, high-throughput omics technologies, and artificial intelligence has generated unprecedented volumes of biological data, creating an urgent need for sophisticated bioinformatics approaches capable of extracting clinically meaningful information. Bioinformatics serves as the computational foundation of precision medicine by integrating genomics, transcriptomics, proteomics, metabolomics, epigenomics, and microbiome data to identify disease-associated biomarkers, predict therapeutic responses, and support personalized clinical decision-making. Recent advances in machine learning, deep learning, network biology, and systems medicine have significantly improved biomarker discovery, disease classification, drug target identification, pharmacogenomics, and precision therapeutics. Bioinformatics has become indispensable in oncology, cardiovascular medicine, neurological disorders, infectious diseases, rare genetic disorders, and immunotherapy, where computational analyses facilitate early diagnosis, prognostic assessment, and individualized treatment strategies. Despite remarkable progress, challenges remain regarding data integration, standardization, interoperability, clinical validation, ethical considerations, cybersecurity, and regulatory implementation. Emerging technologies including single-cell multi-omics, spatial transcriptomics, digital twins, explainable artificial intelligence, quantum computing, and federated learning are expected to further revolutionize computational precision medicine. This review summarizes recent advances in bioinformatics-driven precision medicine, focusing on computational methodologies, biomarker discovery, multi-omics integration, artificial intelligence, personalized therapeutics, current challenges, and future perspectives for improving patient-centered healthcare.
Zitieren
APA
Sharma, V. (2026). Bioinformatics in Precision Medicine: Recent Advances in Biomarker Discovery, Multi-Omics Integration, and Personalized Therapeutics. Biotechnology Frontiers, 6(1), 68-71. https://doi.org/10.51470/bf.2026.6.1.68
Vancouver
Sharma V. Bioinformatics in Precision Medicine: Recent Advances in Biomarker Discovery, Multi-Omics Integration, and Personalized Therapeutics. Biotechnology Frontiers. 2026;6(1):68-71. doi:10.51470/bf.2026.6.1.68
BibTeX
@article{Sharma2026,
author = {Sharma, Vaishnavi},
title = {Bioinformatics in Precision Medicine: Recent Advances in Biomarker Discovery, Multi-Omics Integration, and Personalized Therapeutics},
journal = {Biotechnology Frontiers},
year = {2026},
volume = {6},
number = {1},
pages = {68--71},
doi = {10.51470/bf.2026.6.1.68}
}
EUVIMED